A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases - Quiz - MDSpire

A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases

  • By

  • Sebastian Jeising

  • Ann-Christin Nickel

  • Johanna Trübel

  • Jörg Felsberg

  • Daniel Picard

  • Gabriel Leprivier

  • Marietta Wolter

  • My Ky Huynh

  • Marlene B. Olivera

  • Kerstin Kaulich

  • Lena Häberle

  • Irene Esposito

  • Gunnar W. Klau

  • Julia Steinmann

  • Thomas Beez

  • Marion Rapp

  • Michael Sabel

  • Sascha Dietrich

  • Marc Remke

  • Jan F. Cornelius

  • Guido Reifenberger

  • Nan Qin

  • July 10, 2024

  • 0 min

Share

Original Source(s)

A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases

  • by Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, Jörg Felsberg, Daniel Picard, Gabriel Leprivier, Marietta Wolter, My Ky Huynh, Marlene B. Olivera, Kerstin Kaulich, Lena Häberle, Irene Esposito, Gunnar W. Klau, Julia Steinmann, Thomas Beez, Marion Rapp, Michael Sabel, Sascha Dietrich, Marc Remke, Jan F. Cornelius, Guido Reifenberger, Nan Qin

  • July 10, 2024

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer